Inactive Instrument

CompuMed, Inc. Stock Other OTC

Equities

CMPD

US2049144023

Healthcare Facilities & Services

Sales 2009 2.05M Sales 2010 1.76M Capitalization 2.46M
Net income 2009 - Net income 2010 - EV / Sales 2009 1.88 x
Net cash position 2009 30K Net Debt 2010 72K EV / Sales 2010 1.43 x
P/E ratio 2009
-13.1 x
P/E ratio 2010
-5.17 x
Employees -
Yield 2009 *
-
Yield 2010
-
Free-Float 5.06%
More Fundamentals * Assessed data
Dynamic Chart
CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient Care CI
CompuMed Integrates the Techcyte Digital Pathology Reviewing Platform to Help Increase Transplanted Organs CI
Compumed, Inc. Announces Resignation of David Pointer as A Chairman and Director of the Company CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on June 12, 2023. CI
CompuMed, Inc. announces an Equity Buyback for 362,168 shares, representing 21.57% for $0.72 million. CI
CompuMed, Inc.'s Equity Buyback announced on June 12, 2023, has closed with 362,168 shares, representing 21.57% for $0.72 million. CI
CompuMed, Inc. authorizes a Buyback Plan. CI
CompuMed, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2021 CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on December 15, 2017. CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on December 15, 2017. CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on December 15, 2017. CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on December 15, 2017. CI
Tranche Update on CompuMed, Inc.'s Equity Buyback Plan announced on December 15, 2017. CI
CompuMed, Inc.'s Equity Buyback announced on December 15, 2017 has expired. CI
CompuMed, Inc. announces an Increase in Equity Buyback. CI
More news
Managers TitleAgeSince
Chief Executive Officer 55 14-10-29
Director of Finance/CFO - -
Chairman 54 13-12-22
Members of the board TitleAgeSince
Chairman 54 13-12-22
Chief Executive Officer 55 14-10-29
Director/Board Member - 16-11-01
More insiders
CompuMed, Inc. provides diagnostic telemedicine solutions. Its telecardiology and teleradiology solutions provide direct access to United States Board-Certified specialists through cloud-based technology and integrated medical devices. Its solutions support the diagnosis and treatment of high incidence diseases, including cardiovascular disease. It has established a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms, ultrasound studies and X-rays. It has also created an electronic telemedicine infrastructure to link clinical diagnostic equipment data collected at the patient’s point of care with top specialists. It also provides real-time access to specialists for consultations. It is also providing single lead ECG interpretations for the consumer market through a handheld device. Its services are available 24 hours a day, seven days per week. It contracts with certain partners to develop diagnostic systems, which support its telemedicine workflow.
More about the company